Anaphylaxis events following COVID-19 antiviral and neutralising monoclonal antibody treatment for non-hospitalised patients: data from the OpenSAFELY-TPP platform (2023)
Attributed to:
OpenSAFELY, ISARIC, PHOSP: tracking consequences of COVID-19 infection across UK primary and secondary care.
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.19704.1
Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.19704.1
Type: Journal Article/Review
Parent Publication: Wellcome Open Research